The association of early post-transplant glucose levels with long-term mortality.
about
Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for managementDiagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation SocietiesNew-onset diabetes mellitus after kidney transplantation: Current status and future directionsTacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic EffectsInfluencing factors of new-onset diabetes after a renal transplant and their effects on complications and survival rate.Dipeptidyl peptidase IV inhibitor MK-0626 attenuates pancreatic islet injury in tacrolimus-induced diabetic ratsProceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions.Novel views on new-onset diabetes after transplantation: development, prevention and treatment.Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot StudyConversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation.Effect of Exendin-4 on Autophagy Clearance in Beta Cell of Rats with Tacrolimus-induced Diabetes Mellitus.Genetics of new-onset diabetes after transplantation.Prevention and management of transplant-associated diabetes.Complications associated with new-onset diabetes after kidney transplantation.New-onset diabetes after kidney transplantation-changes and challenges.New therapeutic paradigm for patients with cirrhosis.Tolerance--is it worth it?The diagnosis of posttransplantation diabetes mellitus: meeting the challenges.Emerging treatments for post-transplantation diabetes mellitus.Diagnostic accuracy of glycated hemoglobin for post-transplantation diabetes mellitus after kidney transplantation: systematic review and meta-analysis.Diabetes Mellitus Following Renal Transplantation: Clinical and Pharmacological Considerations for the Elderly Patient.Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective study.Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria.An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantationClinical evolution of post-transplant diabetes mellitus.New-onset diabetes after liver transplantation and its impact on complications and patient survival.A Prospective Study of Renal Transplant Recipients: A Fall in Insulin Secretion Underpins Dysglycemia After Renal Transplantation.Single-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant.The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival.mTOR Inhibition: Reduced Insulin Secretion and Sensitivity in a Rat Model of Metabolic Syndrome.Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial.Ginseng extract reduces tacrolimus-induced oxidative stress by modulating autophagy in pancreatic beta cells.Impact of renal transplantation on glucose tolerance in Japanese recipients with impaired glucose tolerance.New onset diabetes after kidney transplantation is associated with increased mortality-A retrospective cohort study.The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats.Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells.Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation.Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation.Post-transplantation diabetes mellitus: evaluation of treatment strategies.Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation.
P2860
Q26795773-9391FD5B-C5A9-48F0-A112-C52A5771A3E5Q27024676-2959CB91-22FC-4371-9254-15CDD6C41777Q28083882-539EC381-B7BC-4263-8B90-AE989BB02660Q28551091-918BB67C-4A74-4F7B-B084-914EFFA161D8Q33728526-501C5726-78DF-4754-A902-FF09CBED0A92Q35193875-7023B128-3629-4B82-A109-75E27A857CD1Q35219625-C5C59442-54B5-43AD-B316-D48481E9B60FQ35221336-4042DC13-4BFE-4E28-8B4D-6D4140DCBC34Q36717018-A782C994-CECE-4810-A0BA-70E5BA358982Q36899502-850564EF-1FCF-4F62-A41E-44579E30550AQ37111103-831ADDAA-E1EB-4FD5-B36F-A9C531C64D18Q37733563-B314A170-AF9D-4944-8A75-0EB778E97C4AQ37952000-46D15DD6-C273-489A-86B2-63116193AEC4Q37956123-EA8024BA-B9CE-4E65-B73B-ECAAF2FA4829Q37962217-CB1DA9BC-87E6-4984-B0EE-C77B42BA0AEAQ38021413-78D3DD32-ED56-4D5E-BD2F-4791A27F4734Q38174023-F794128C-96F0-4682-A474-DC08D1E12F62Q38380573-31AE8863-51B7-423C-9BA8-436ABD3CF1AFQ38445269-0E2C2617-9D93-451D-B56D-D902DEE59022Q39020117-C48450A7-8F3D-4E07-8285-8FF2667297DCQ39441009-5B345EC2-C511-4BEB-A414-4D7622359D27Q40708552-6882D572-5825-4FAD-8727-E4CDDDB31EFAQ40910676-C230EDEC-BC75-4129-91C8-F3B482FB0B58Q41015774-78EB481F-4993-471E-8834-C0333E2B3FDCQ41148650-725472C4-22A0-48CF-843D-042C7DA2AFFBQ41486937-3ED02EFB-4BBD-4756-9D5B-641148C1558FQ41676623-BFCBAD27-5677-47C4-A53C-41FC3A6F6FECQ41681683-408EB3B4-9F5C-4247-9DD0-C1F7FCBAD5C9Q42248317-E47618DF-B84C-4BB6-B31C-57ECDFF7D132Q42418240-EC2BD44B-8361-455A-BD56-13DDEE13B24DQ44120755-21AA4E01-D66C-4600-B922-823C34CEB24CQ46328411-F9666F53-DDA6-4992-B932-48C8E3B2BFB9Q47719237-C7E9C6DE-5501-4A51-AF19-6FF39E37B4C7Q48366418-62F092DB-C542-4B0F-8038-BFD4539DD72AQ51013418-2F263FA5-0E78-4A24-9F6B-0A8015232401Q51040538-2ADF33D0-80D7-461D-9424-A6A2D8607E63Q51276197-D511CE61-6B6D-4E5F-8969-BA53CD6372B3Q51303036-1258FF7F-04EB-4F3A-AF9F-32D325581C1CQ51306359-94733381-34B6-4F2D-9E02-CB28E1928537Q51328144-6C5002A6-5780-457D-8662-D3C8E4E8962F
P2860
The association of early post-transplant glucose levels with long-term mortality.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The association of early post-transplant glucose levels with long-term mortality.
@ast
The association of early post-transplant glucose levels with long-term mortality.
@en
The association of early post-transplant glucose levels with long-term mortality.
@nl
type
label
The association of early post-transplant glucose levels with long-term mortality.
@ast
The association of early post-transplant glucose levels with long-term mortality.
@en
The association of early post-transplant glucose levels with long-term mortality.
@nl
prefLabel
The association of early post-transplant glucose levels with long-term mortality.
@ast
The association of early post-transplant glucose levels with long-term mortality.
@en
The association of early post-transplant glucose levels with long-term mortality.
@nl
P2093
P2860
P1433
P1476
The association of early post-transplant glucose levels with long-term mortality
@en
P2093
A Hartmann
H A Bergrem
J Hjelmesæth
T G Valderhaug
T Leivestad
P2860
P2888
P304
P356
10.1007/S00125-011-2105-9
P577
2011-03-16T00:00:00Z
P5875
P6179
1030807427